Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M22,876Revenue $M4,785Net Margin (%)12.2Z-Score4.3
Enterprise Value $M25,670EPS $1.2Operating Margin %19.7F-Score8
P/E(ttm))39.4Cash Flow Per Share $0Pre-tax Margin (%)17.1Higher ROA y-yY
Price/Book17.510-y EBITDA Growth Rate %0Quick Ratio2.0Cash flow > EarningsY
Price/Sales4.75-y EBITDA Growth Rate %0Current Ratio3.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %13.4ROA % (ttm)8.9Higher Current Ratio y-yY
Dividend Yield %0.7Insider Buy (3m)0ROE % (ttm)49.0Less Shares Outstanding y-yN
Payout Ratio %25.0Shares Outstanding M501ROI % (ttm)8.4Gross Margin Increase y-yY

Gurus Latest Trades with ZTS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ZTSVanguard Health Care Fund 2015-03-31 Reduce-0.3%$42.63 - $47.51
($45.09)
$ 45.401%Reduce -32.72%6,175,407
ZTSMario Gabelli 2015-03-31 Reduce$42.63 - $47.51
($45.09)
$ 45.401%Reduce -1.93%614,785
ZTSBill Ackman 2014-12-31 Add9.62%$35.07 - $44.93
($40.72)
$ 45.4010%Add 650.78%41,569,646
ZTSRobert Olstein 2014-12-31 Reduce-0.18%$35.07 - $44.93
($40.66)
$ 45.4010%Reduce -20.79%141,000
ZTSVanguard Health Care Fund 2014-12-31 Reduce-0.15%$35.07 - $44.93
($40.66)
$ 45.4010%Reduce -15.00%9,178,657
ZTSJean-Marie Eveillard 2014-12-31 Reduce-0.12%$35.07 - $44.93
($40.66)
$ 45.4010%Reduce -62.26%820,467
ZTSMario Gabelli 2014-12-31 Add0.09%$35.07 - $44.93
($40.66)
$ 45.4010%Add 187.59%626,893
ZTSJohn Keeley 2014-12-31 Reduce-0.01%$35.07 - $44.93
($40.66)
$ 45.4010%Reduce -21.81%62,164
ZTSBill Ackman 2014-09-30 Buy 1.5%$31.79 - $37.2
($34.27)
$ 45.4025%New holding5,536,862
ZTSJoel Greenblatt 2014-09-30 Sold Out -0.01%$31.79 - $37.2
($34.27)
$ 45.4025%Sold Out0
ZTSJean-Marie Eveillard 2014-06-30 Reduce-0.12%$28.4 - $32.89
($30.65)
$ 45.4032%Reduce -42.15%2,177,060
ZTSGeorge Soros 2014-06-30 Add0.05%$28.4 - $32.89
($30.65)
$ 45.4032%Add 4.32%4,386,635
ZTSVanguard Health Care Fund 2014-06-30 Add0.03%$28.4 - $32.89
($30.65)
$ 45.4032%Add 3.61%10,798,417
ZTSRuane Cunniff 2014-06-30 Add$28.4 - $32.89
($30.65)
$ 45.4032%Add 0.01%173,562
ZTSJohn Keeley 2014-06-30 Reduce$28.4 - $32.89
($30.65)
$ 45.4032%Reduce -5.82%74,504
ZTSJoel Greenblatt 2014-06-30 Reduce$28.4 - $32.89
($30.65)
$ 45.4032%Reduce -22.04%33,034
ZTSMario Gabelli 2014-06-30 Reduce$28.4 - $32.89
($30.65)
$ 45.4032%Reduce -6.74%242,980
ZTSGeorge Soros 2014-03-31 Add0.49%$29.01 - $32.69
($30.64)
$ 45.4033%Add 68.52%4,205,043
ZTSJean-Marie Eveillard 2014-03-31 Reduce-0.26%$29.01 - $32.69
($30.64)
$ 45.4033%Reduce -43.39%3,763,386
ZTSVanguard Health Care Fund 2014-03-31 Add0.16%$29.01 - $32.69
($30.63)
$ 45.4033%Add 23.89%10,421,717
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ZTS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ZTS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MCCALLISTER MICHAEL BDirector 2013-08-08Buy7,000$31.3542.3view
Knupp Catherine A.Executive Vice President 2013-02-06Buy1,000$2671.58view
Chen Heidi C.Executive Vice President 2013-02-06Buy2,500$2671.58view
Beaty Sandra J.Executive Vice President 2013-02-06Buy2,000$2671.58view
STEERE WILLIAM C JRDirector 2013-02-06Buy4,500$2671.58view
Norden GregoryDirector 2013-02-06Buy3,000$2671.58view
SCHULMAN AMY WDirector 2013-02-06Buy5,000$2671.58view
HILL CHARLES HDirector 2013-02-06Buy5,000$2671.58view
Giordano Douglas E.Director 2013-02-06Buy5,000$2671.58view
Germano Geno JDirector 2013-02-06Buy5,000$2671.58view

Press Releases about ZTS :

    Quarterly/Annual Reports about ZTS:

    News about ZTS:

    Articles On GuruFocus.com
    Bill Ackman is keeping on buying Zoetis Feb 24 2015 
    Activist Investor Bill Ackman's Newest Additions to His Portfolio Feb 18 2015 
    Feeling Good With This Med Company Jan 20 2015 
    2015 - First Half Jan 01 2015 
    Zoetis in a Growing Global Animal Health Industry Dec 03 2014 
    Ackman’s Pershing Group Buys Stake in Zoetis Nov 13 2014 
    Activist Bill Ackman Buys Big Stake In Animal Healthcare Company Zoetis Nov 12 2014 
    Zoetis Will Benefit from Industry Trends Oct 07 2014 
    Guru Stocks at 52-Week Lows: HMC, NMR, SDRL, ZTS, BBBY Apr 21 2014 
    Morning Coffee: Widely Held Guru Stocks Near 52-Week Lows Apr 10 2014 

    More From Other Websites
    ZOETIS INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 01 2015
    Zoetis Holds Annual Meeting of Shareholders May 01 2015
    Zoetis Holds Annual Meeting of Shareholders May 01 2015
    Zoetis to Participate in the BMO Capital Markets 10th Annual Farm to Market Conference Apr 28 2015
    Abbott Labs Reports Better-Than-Expected Profit Apr 22 2015
    Abbott profit beats expectations, sales of branded generics jump Apr 22 2015
    Zoetis to Participate in the Bank of America Merrill Lynch 2015 Health Care Conference Apr 14 2015
    Zoetis adds second director under deal with Pershing Square Apr 13 2015
    Actavis Chairman Bisaro Joins Zoetis Board With Ackman Blessing Apr 13 2015
    Zoetis Appoints Paul M. Bisaro to Board of Directors Apr 13 2015
    Zoetis adds 2nd director to board under deal with Pershing Square Apr 13 2015
    ZOETIS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... Apr 13 2015
    Zoetis Appoints Paul M. Bisaro to Board of Directors Apr 13 2015
    Highfields Capital Adds Zoetis to Its 4Q14 Portfolio Apr 06 2015
    Bill Ackman maintains large exposure to health-care sector with new Valeant stake Mar 31 2015
    Zoetis to Host Webcast and Conference Call on First Quarter 2015 Financial Results Mar 31 2015
    Zoetis to Host Webcast and Conference Call on First Quarter 2015 Financial Results Mar 31 2015
    The young & the restless: 6 who are hot Mar 27 2015
    With New Valeant Pharmaceuticals Intl Inc (VRX) Stake, Bill Ackman Maintains Large Exposure to... Mar 26 2015
    Zoetis Call-Buyers at Work in Shares of the Animal Health Company Mar 26 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK